What is Zetta Genomics?
Zetta Genomics operates at the intersection of bioinformatics and enterprise-level data management. Its flagship platform, XetaBase, serves as a foundational technology designed to bridge the gap between raw genomic sequencing and actionable clinical insights. By providing a robust architecture for the storage, retrieval, and analysis of complex biological datasets, the company enables researchers and clinicians to streamline workflows that were previously hindered by data silos and computational bottlenecks. The firm's market position is defined by its focus on genomic-native solutions, which are essential for the next generation of personalized healthcare and diagnostic precision.
How much funding has Zetta Genomics raised?
Zetta Genomics has raised a total of $7.7M across 1 funding round:
Angel/Seed
$7.7M
Angel/Seed (2024): $7.7M with participation from APEX Ventures, Cambridge Enterprise, Nina Capital, and We Venture Capital
Key Investors in Zetta Genomics
APEX Ventures
APEX Ventures is a venture capital firm focused on deep-tech and medical innovations, aiming to build the next generation of world-leading companies.
Nina Capital
Nina Capital is a specialized venture capital firm focused on investing in health technology companies at the pre-seed and seed stages, specifically targeting need-driven founders.
Cambridge Enterprise
Cambridge Enterprise is the commercialization arm of the University of Cambridge, supporting the translation of research into impactful commercial ventures.
What's next for Zetta Genomics?
Looking ahead, the strategic roadmap for Zetta Genomics involves scaling the XetaBase platform to meet the increasing demand for high-throughput genomic processing in clinical settings. The company is expected to prioritize the integration of its technology into broader healthcare ecosystems, facilitating a more seamless transition from research-grade data to bedside decision-making. As the industry shifts toward data-driven therapeutic development, Zetta Genomics is poised to become a critical utility provider for life sciences organizations. Future growth will likely focus on enhancing real-time analytical capabilities and expanding partnerships with major research institutions to solidify its role as a leader in the genomic data infrastructure space.
See full Zetta Genomics company page
